On March 26, 2009, Roche completed its acquisition of Genentech and our common stock ceased trading on this date. Information related to Roche stock may be found at the Roche Group website.
Following is a timeline of Genentech stock-related events. Please note that all numbers below relating to the number of shares and price per share of our Common Stock, Redeemable Common Stock and Special Common Stock reflect the number of shares and prices at the time of the event. The numbers provided do not give effect to the 3-for-2 stock split in March 1983 nor the 2-for-1 stock splits in February 1986, February 1987, November 1999, October 2000, and May 2004.
| October 14, 1980
Initial Public Offering (IPO)
1,000,000 shares offered at $35.00 Genentech stock trades on NASDAQ under symbol GENE |
| March 30, 1983
Payable date of 3-for-2 stock split |
| March 15, 1985
Follow-on Public Offering
1,000,000 shares offered at $45.00 |
| February 28, 1986
Payable date of 2-for-1 stock split |
| February 27, 1987
Payable date of 2-for-1 stock split |
| March 2, 1988
Genentech stock begins trading on the NYSE under the symbol GNE |
| September 7, 1990
Genentech and Roche Merger approved by stockholders
Each share of Genentech Common Stock (CUSIP 368 710 109) is exchanged for $18 in cash plus one-half share of Genentech Redeemable Common Stock (CUSIP 368 710 208) |
| October 25, 1995
Genentech stockholders approve Roche's extended buyout option
Each share of Genentech Redeemable Common Stock (CUSIP 368 710 208) is exchanged for one share of Genentech Callable Putable Common Stock (also known as Genentech Special Common Stock - CUSIP 368 710 307) |
| June 14, 1999
Roche exercises its Call Option for all outstanding shares of Genentech Special Common Stock - redemption date set for June 30, 1999 |
| June 16, 1999
Last day of trading of Genentech Special Common Stock |
| June 30, 1999
Genentech redeems its Special Common Stock
Each share of Genentech Special Common Stock (CUSIP 368 710 307) is exchanged for $82.50 in cash (except for those shares held by Roche) |
| July 19, 1999
Roche sells shares of Genentech Common Stock in a Public Offering
22,000,000 shares offered at $97.00 Genentech stock begins trading on NYSE on July 20, 1999 under the symbol DNA (CUSIP 368 710 406). |
| October 20, 1999
Roche sells shares of Genentech Common Stock in a Public Offering
20,000,000 shares offered at $143.50; shares begin trading on NYSE on October 21, 1999. |
| November 2, 1999
Payable date of 2-for-1 stock split |
| March 23, 2000
Roche sells shares of Genentech Common Stock in a Public Offering
17,300,000 shares offered at $167.25; shares begin trading on NYSE on March 24, 2000. |
| October 24, 2000
Payable date of 2-for-1 stock split |
| May 12, 2004
Payable date of 2-for-1 stock split |
| March 26, 2009
Roche acquires all of Genentech Common Stock (CUSIP 368 710 406) at $95 per share. Last day of trading of Genentech Common Stock. |